Literature DB >> 3016538

Impaired specific cellular response to HTLV-III before other immune defects in patients with HTLV-III infection.

B Wahren, L Morfeldt-Månsson, G Biberfeld, L Moberg, P Ljungman, S Nordlund, U Bredberg-Rådén, A Werner, J Löwer, R Kurth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3016538

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  RNA-mediated transfer of cellular immunity to a synthetic env antigen of the human immunodeficiency virus (HIV-1).

Authors:  G A Passos Júnior; F L de Lucca
Journal:  Mol Cell Biochem       Date:  1991-11-13       Impact factor: 3.396

2.  Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.

Authors:  K Krohn; W G Robey; S Putney; L Arthur; P Nara; P Fischinger; R C Gallo; F Wong-Staal; A Ranki
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1.

Authors:  A C Leandersson; G Gilljam; M Fredriksson; J Hinkula; A Alaeus; K Lidman; J Albert; G Bratt; E Sandström; B Wahren
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Epitope mapping of monoclonal antibodies against human immunodeficiency virus type 1 structural proteins by using peptides.

Authors:  M Niedrig; J Hinkula; W Weigelt; J L'age-Stehr; G Pauli; J Rosen; B Wahren
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

5.  Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro.

Authors:  J F Krowka; D P Stites; S Jain; K S Steimer; C George-Nascimento; A Gyenes; P J Barr; H Hollander; A R Moss; J M Homsy
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

6.  Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection.

Authors:  B Wahren; L Morfeldt-Månsson; G Biberfeld; L Moberg; A Sönnerborg; P Ljungman; A Werner; R Kurth; R Gallo; D Bolognesi
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

7.  Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein.

Authors:  S Abrignani; D Montagna; M Jeannet; J Wintsch; N L Haigwood; J R Shuster; K S Steimer; A Cruchaud; T Staehelin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

8.  Mycobacterium avium infection in HIV-1-infected subjects increases monokine secretion and is associated with enhanced viral load and diminished immune response to viral antigens.

Authors:  M Denis; E Ghadirian
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

9.  Cell-mediated immunity to HIV-1 in Walter Reed stages 1-6 individuals: correlation with virus burden.

Authors:  R J Trauger; W K Giermakowska; F Ferre; P C Duffy; M R Wallace; D E Lewis; H J Beecham; K G Burnett; F C Jensen; D J Carlo
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

10.  Immunological changes in cats with concurrent Toxoplasma gondii and feline immunodeficiency virus infections.

Authors:  D S Lin; D D Bowman; R H Jacobson
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.